NDC 0113-0431 Good Sense Nighttime Sleep Aid

Good Sense Nighttime Sleep Aid with NDC 0113-0431 is a a human over the counter drug product labeled by L. Perrigo Company. The generic name of Good Sense Nighttime Sleep Aid is diphenhydramine hydrochloride. The product's dosage form is tablet, film coated and is administered via oral form. The RxNorm Crosswalk for this NDC code indicates a single RxCUI concept is associated to this product: 1049630.

Dosage Form: Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Good Sense Nighttime Sleep Aid Active Ingredient(s)

• DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1

Inactive Ingredient(s)

• CARNAUBA WAX (UNII: R12CBM0EIZ)
• CROSPOVIDONE (15 MPA.S AT 5%) (UNII: 68401960MK)
• DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)
• HYPROMELLOSES (UNII: 3NXW29V3WO)
• MAGNESIUM STEARATE (UNII: 70097M6I30)
• CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
• POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)
• POLYSORBATE 80 (UNII: 6OZP39ZG8H)
• STEARIC ACID (UNII: 4ELV7Z65AP)
• TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
• FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
• FD&C BLUE NO. 2 (UNII: L06K8R7DQK)

Administration Route(s)

• Oral - Administration to or by way of the mouth.

Pharmacological Class(es)

• Histamine H1 Receptor Antagonists - [MoA] (Mechanism of Action)
• Histamine-1 Receptor Antagonist - [EPC] (Established Pharmacologic Class)

Product Labeler Information

Labeler Name: L. Perrigo Company
Labeler Code: 0113
FDA Application Number: part338 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Marketing Category: OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Start Marketing Date: 04-25-2001 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.
Listing Expiration Date: 12-31-2023 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.
Exclude Flag: N - NO What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".

* Please review the disclaimer below.